Pediatric Oncology Consultant
Gustave Roussy Cancer Centre, France
Pablo Berlanga MD, PhD, is a pediatric oncologist at Gustave Roussy Cancer Campus. He trained in paediatric oncology at the Hospital La Fe Hospital in Valencia, Spain and then worked as a paediatric oncology consultant until 2017 when he moved to France. He is actively involved in paediatric phase I/II trials and precision medicine program, soft and bone tissue sarcomas and neuroblastoma. He is an active member of the new drug development committees of SIOPEN, EpSSG, EuroEwing and FOSTEr Consortiums. He is member of the ITCC Solid Tumour Steering Committee, where he participates in the review of phase I/II clinical trial of extra cranial solid tumors.
He is the Principal Investigator of the SACHA- France study (Secured Access to innovative medicines for CHildren with cAncer, NCT04477681) and the phase Ib REGO-INTER-EWING (regorafenib in combination with conventional first line treatment for patients with multimetastatic Ewing sarcoma), developed within the EuroEwing Consortium.
